Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension.

[1]  S. Blair,et al.  Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. , 1985, American heart journal.

[2]  E. Braunwald,et al.  Circadian variation in the frequency of onset of acute myocardial infarction. , 1985, The New England journal of medicine.

[3]  S. Willich,et al.  Circadian variation in the frequency of sudden cardiac death. , 1987, Circulation.

[4]  E F Cook,et al.  Circadian variation of transient myocardial ischemia in patients with coronary artery disease. , 1987, Circulation.

[5]  P. Deedwania,et al.  Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. , 1990, Circulation.

[6]  Myocardial ischemia during daily activities: the importance of increased myocardial oxygen demand. , 1991, Journal of the American College of Cardiology.

[7]  A. Quyyumi,et al.  Circadian Variation in Ischemic Threshold: A Mechanism Underlying the Circadian Variation in Ischemic Events , 1992, Circulation.

[8]  R B D'Agostino,et al.  Influence of heart rate on mortality among persons with hypertension: the Framingham Study. , 1993, American heart journal.

[9]  W. White,et al.  Effects of actual versus arbitrary awake and sleep times on analyses of 24-h blood pressure. , 1995, American journal of hypertension.

[10]  K. Kario,et al.  Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. , 1996, Hypertension.

[11]  Circadian variation of blood pressure. , 1996 .

[12]  H30: Symptoms and the distress they cause during antihypertensive therapy: Comparison of calcium channel blockade with nifedipine gits and COER-verapamil , 1997 .

[13]  S. Julius,et al.  Heart rate and the cardiovascular risk , 1997, Journal of hypertension.

[14]  A. Zanchetti,et al.  Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. , 1998, Controlled clinical trials.

[15]  H. Black,et al.  Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. , 1998, The American journal of cardiology.